Scientists Reveal Adipocyte’s Metabolic Role and Identify Treatment Targets
Human adipocyte with lipid droplet labeled in magenta and regulatory protein in green.
(c) Helmholtz Munich / Felix Klingelhuber
Recent research underscores the critical role of adipocytes in storing fat, vital for organismal survival. Dysfunctional adipocytes can lead to metabolic disorders like type 2 diabetes and fatty liver disease, highlighting the importance of understanding lipid storage mechanisms. A team of scientists led by Helmholtz Munich have developed a novel approach merging proteomics with machine learning to map dynamic changes during adipogenesis. This method reveals new insights into protein regulation, offering potential targets for managing metabolic diseases.
Unlocking the Secrets of Fat Storage
Living organisms have evolved the remarkable ability to store energy in the form of fat, a vital adaptation crucial for survival. In periods of energy abundance, this fat is stored within specialized cells called adipocytes, ensuring a reserve for times of scarcity. Unlike many other cell types that struggle with lipid management and can suffer from lipid toxicity, adipocytes excel in storing significant amounts of fat. On average, a healthy adult carries between 10 to 25 kilograms of fat, primarily housed in adipose tissue, with each kilogram harboring roughly 9,000 kilocalories of energy.
However, when adipocytes malfunction, it can lead to metabolic disorders. Inefficient fat storage by adipocytes results in fat accumulation in other bodily regions, contributing to conditions such as type 2 diabetes and fatty liver disease. Therefore, comprehending the intricate cellular mechanisms governing lipid storage in adipocytes is imperative. Such understanding opens avenues for identifying novel pharmacological targets to regulate adipocyte function. Ultimately, this knowledge holds promise for developing innovative treatments aimed at managing and preventing metabolic disorders associated with adipocyte dysfunction.
Mapping Cellular Changes in Adipogenesis
Adipocytes emerge from precursor cells nestled within adipose tissue through a process called adipogenesis. Yet the intricacies of this transformation, particularly how cells restructure themselves to optimize lipid storage capabilities, have long puzzled researchers. Pioneering a novel approach, scientists from Helmholtz Munich, the Karolinska Institute in Stockholm, and the German Center for Diabetes Research (DZD) have merged proteomics with machine learning to construct time-resolved cellular maps of adipogenesis. Through this innovative method, researchers can capture snapshots of cellular dynamics, providing unprecedented insights into the remodeling of cellular compartments and, for the first time, tracking the dynamic shifts in protein localization during this process.
“We’ve successfully mapped previously unseen alterations in cellular architecture within fat cells as they undergo specialization for fat storage. By capturing snapshots of these cells throughout their developmental stages using proteomic techniques, we’ve identified novel regulators involved in both fat storage and mobilization,” explains Dr. Natalie Krahmer, the lead researcher of the study.
Key Proteins with Obesity Treatment Potential
Their discoveries have revealed that a remarkable 20 percent of all proteins change localization, emphasizing the critical role of protein placement in cell specialization. Through their method, they have unveiled the synchronized regulation of protein levels and localization, laying the groundwork for efficient lipid storage. Moreover, the researcher identified novel regulators of lipid storage, exposing previously unknown proteins associated with lipid droplets – the vital structures facilitating lipid storage within cells. Interestingly, the absence of one such protein prevents cells from mobilizing stored lipids, resulting in excessive lipid accumulation. Importantly, analysis of patient data has highlighted a correlation between reduced levels of this protein in adipose tissue and obesity. This significant finding underscores the clinical relevance of the protein, suggesting its potential as a pivotal determinant of adipocyte capacity to mobilize stored fat and as a promising target for the development of obesity treatments.
Wissenschaftliche Ansprechpartner:
Dr. Natalie Krahmer, Emmy Noether Research Group Leader ‘Cellular Proteomics and Metabolic Signaling’ at the Helmholtz Munich Institute of Diabetes and Obesity and researcher at the German Center for Diabetes Research (DZD)
Email: natalie.krahmer@helmholtz-munich.de
Originalpublikation:
Klingelhuber et al., 2024: A spatiotemporal proteomic map of human adipogenesis. Nature Metabolism, DOI: 10.1038/s42255-024-01025-8
https://www.nature.com/articles/s42255-024-01025-8
Media Contact
All latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
SpinMagIC: ‘EPR on a chip’ ensures quality of olive oil and beer
Spin-off company offers a tiny solution for a big problem. The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and…
Impressive results against autoimmune disease
Severe systemic lupus no longer detectable after cancer medication treatment. The team at Charité – Universitätsmedizin Berlin is astounded by the huge improvement seen in a female patient with severe…
UCF researchers develop rapid test to detect dopamine
The sensor could serve as a low-cost and efficient tool for early detection of neurological disorders and conditions, including Parkinson’s disease, Alzheimer’s disease and depression. Dopamine, a neurotransmitter in our…